📅Offer Date: 16 Jul 2021 – 20 Jul 2021
Data sourced from BSE & NSE · Last updated
Tatva Chintan Pharma Chem Limited IPO was subscribed 182.04x in total when bidding closed on 20 Jul 2021, with 186.96x in the QIB category, 516.99x in NII, 35.67x in retail. The issue ran from 16 Jul 2021 to 20 Jul 2021 at a price band of ₹1073.00–₹1083.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (35.67x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 9,31,966 | 17,42,40,363 | 186.96x |
| NIIs | 6,98,975 | 36,13,63,085 | 516.99x |
| Retail | 16,30,941 | 5,81,75,665 | 35.67x |
| Total | 32,61,882 | 59,37,92,999 | 182.04x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 100.93 | 18870.23 | 186.96x |
| NIIs | 75.70 | 39135.62 | 516.99x |
| Retail | 176.63 | 6300.42 | 35.67x |
| Total | 353.26 | 64306.28 | 182.04x |
Values derived from share count × issue price (₹1083.00)
Because Tatva Chintan Pharma Chem Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.